Semjon Willier

1.0k total citations
21 papers, 707 citations indexed

About

Semjon Willier is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Semjon Willier has authored 21 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Semjon Willier's work include CAR-T cell therapy research (15 papers), Virus-based gene therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Semjon Willier is often cited by papers focused on CAR-T cell therapy research (15 papers), Virus-based gene therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Semjon Willier collaborates with scholars based in Germany, United States and France. Semjon Willier's co-authors include Thomas G. P. Grünewald, Tobias Feuchtinger, Franziska Blaeschke, Theresa Kaeuferle, Elke Butt, Dana Stenger, Ramin Lotfi, Judith Feucht, Michaela Döring and Mario Assenmacher and has published in prestigious journals such as Blood, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Semjon Willier

19 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Semjon Willier Germany 11 422 343 175 131 94 21 707
Pilvi Maliniemi Finland 10 272 0.6× 248 0.7× 138 0.8× 92 0.7× 62 0.7× 16 505
Sanfang Tu China 16 582 1.4× 297 0.9× 201 1.1× 154 1.2× 144 1.5× 52 858
Frederic B. Thalheimer Germany 13 494 1.2× 377 1.1× 195 1.1× 240 1.8× 148 1.6× 24 744
Christine Alewine United States 18 517 1.2× 295 0.9× 395 2.3× 57 0.4× 58 0.6× 51 1.1k
Smita S. Chandran United States 13 670 1.6× 261 0.8× 682 3.9× 131 1.0× 106 1.1× 19 1.0k
Kelly M. Ramsbottom Australia 16 462 1.1× 414 1.2× 654 3.7× 45 0.3× 76 0.8× 22 1.0k
Talía Velasco-Hernández Spain 12 358 0.8× 367 1.1× 125 0.7× 54 0.4× 27 0.3× 20 692
Tamara Tripic United States 6 221 0.5× 335 1.0× 163 0.9× 103 0.8× 25 0.3× 9 596
Sebastian Newrzela Germany 16 481 1.1× 358 1.0× 258 1.5× 278 2.1× 42 0.4× 29 844
Xiuqi Wu China 9 557 1.3× 299 0.9× 355 2.0× 121 0.9× 129 1.4× 13 816

Countries citing papers authored by Semjon Willier

Since Specialization
Citations

This map shows the geographic impact of Semjon Willier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semjon Willier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semjon Willier more than expected).

Fields of papers citing papers by Semjon Willier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Semjon Willier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semjon Willier. The network helps show where Semjon Willier may publish in the future.

Co-authorship network of co-authors of Semjon Willier

This figure shows the co-authorship network connecting the top 25 collaborators of Semjon Willier. A scholar is included among the top collaborators of Semjon Willier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Semjon Willier. Semjon Willier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaeuferle, Theresa, Reinhard Zeidler, Semjon Willier, et al.. (2025). All-in-one CRISPR/Cas-engineered glucocorticoid-receptor knock-out EBV-gp350-CAR knock-in T cells are potent and resistant to dexamethasone. Experimental Hematology and Oncology. 14(1). 40–40.
2.
Willier, Semjon, J L Farber, Dana Stenger, et al.. (2023). CD28 CAR T Cells for the Treatment of T Cell Malignancies. Blood. 142(Supplement 1). 3448–3448. 1 indexed citations
3.
Blaeschke, Franziska, Dana Stenger, Theresa Kaeuferle, et al.. (2022). Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function. Frontiers in Immunology. 13. 845499–845499. 12 indexed citations
4.
Fuchs, Steffen, Loélia Babin, Semjon Willier, et al.. (2022). Generation of full-length circular RNA libraries for Oxford Nanopore long-read sequencing. PLoS ONE. 17(9). e0273253–e0273253. 9 indexed citations
5.
Kaeuferle, Theresa, Stefan Canzar, Semjon Willier, et al.. (2022). Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells. Clinical & Translational Immunology. 11(1). e1372–e1372. 8 indexed citations
6.
Kaeuferle, Theresa, Thomas Müller, Michaela Döring, et al.. (2021). Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections. Molecular Therapy. 30(1). 198–208. 1 indexed citations
7.
Blaeschke, Franziska, Semjon Willier, Dana Stenger, et al.. (2020). Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients. Leukemia. 34(10). 2607–2620. 33 indexed citations
8.
Kaeuferle, Theresa, et al.. (2020). CRISPR-Cas9-Mediated Glucocorticoid Resistance in Virus-Specific T Cells for Adoptive T Cell Therapy Posttransplantation. Molecular Therapy. 28(9). 1965–1973. 21 indexed citations
9.
Rejeski, Kai, Carolina Berger, Semjon Willier, et al.. (2020). Identification of Predictive Markers of Severe and Prolonged Neutropenia after CD19-Specific CAR T-Cell Treatment in Patients with Relapsed/Refractory B-Cell Malignancies. Blood. 136(Supplement 1). 41–42. 1 indexed citations
10.
Willier, Semjon, Maximilian Hastreiter, Dana Stenger, et al.. (2020). CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapy. Blood. 137(8). 1037–1049. 55 indexed citations
11.
Willier, Semjon, Patrick Schlegel, Manon Queudeville, et al.. (2020). <p>Antiemetic Prophylaxis with Fosaprepitant and 5-HT<sub>3</sub>-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation</p>. Drug Design Development and Therapy. Volume 14. 3915–3927. 2 indexed citations
12.
Stenger, Dana, Theresa Kaeuferle, Semjon Willier, et al.. (2020). Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR. Blood. 136(12). 1407–1418. 123 indexed citations
13.
Blaeschke, Franziska, Milan Paul, Martin U. Schuhmann, et al.. (2019). Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy. Cytotherapy. 21(9). 973–986. 31 indexed citations
14.
15.
Kaeuferle, Theresa, et al.. (2019). Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation. Journal of Hematology & Oncology. 12(1). 13–13. 98 indexed citations
16.
17.
Willier, Semjon, Dana Stenger, Theresa Kaeuferle, et al.. (2018). Bone Marrow T Cells Are Driven into Exhaustion By Acute Leukemia in Pediatric Patients Based on Protein and Transcriptome Analysis. Blood. 132(Supplement 1). 3722–3722.
18.
Willier, Semjon, Elke Butt, & Thomas G. P. Grünewald. (2013). Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: A focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays. Biology of the Cell. 105(8). 317–333. 123 indexed citations
19.
Grünewald, Thomas G. P., Semjon Willier, Dirk Janik, et al.. (2013). The Zyxin‐related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth. Biology of the Cell. 105(11). 535–547. 25 indexed citations
20.
Willier, Semjon, Elke Butt, Günther Richter, Stefan Burdach, & Thomas G. P. Grünewald. (2011). Defining the role of TRIP6 in cell physiology and cancer. Biology of the Cell. 103(12). 573–591. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pilvi Maliniemi Breakdown of academic impact, for papers by Sanfang Tu Breakdown of academic impact, for papers by Frederic B. Thalheimer Breakdown of academic impact, for papers by Christine Alewine Breakdown of academic impact, for papers by Smita S. Chandran Breakdown of academic impact, for papers by Kelly M. Ramsbottom Breakdown of academic impact, for papers by Talía Velasco-Hernández Breakdown of academic impact, for papers by Tamara Tripic Breakdown of academic impact, for papers by Sebastian Newrzela Breakdown of academic impact, for papers by Xiuqi Wu
Rankless by CCL
2026